← Browse by Condition
Medical Condition

seizures

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for seizures sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — seizures Clinical Trials

How many clinical trials are currently recruiting for seizures?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for seizures, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for seizures?
seizures research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a seizures clinical trial?
Eligibility criteria for seizures trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
NYU Langone Health 1 trial
University of California, San Francisco 1 trial
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1 trial
yuanli Zhao 1 trial

Recruiting Clinical Trials

NCT03233399
Recruiting
Modulating Movement Intention Via Cortical Stimulation
Enrollment
30 pts
Location
United States
Sponsor
NYU Langone Health
View Trial →
NCT05851391 Phase 2
Recruiting
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
Enrollment
30 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT07234695 Phase 3
Recruiting
LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
Enrollment
120 pts
Location
Spain
Sponsor
Fundació Institut de Recerca d...
View Trial →
NCT04076449
Recruiting
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
Enrollment
200 pts
Location
China
Sponsor
yuanli Zhao
View Trial →

Related Conditions

epilepsy (2) seizure disorder (1) psychogenic movement disorder (1) hypoxia ischemia brain (1) heart arrest (1) status epilepticus (1) refractory status epilepticus (1) anoxic ischemic encephalopathy (1) anoxia ischemia cerebral (1) down syndrome (1) down syndrome ds (1) down syndrome trisomy 21 (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology